Please ensure Javascript is enabled for purposes of website accessibility

Foolish Forecast: Dissecting Silicon Labs

By Rich Smith – Updated Nov 15, 2016 at 4:33PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Views you can use to get clues on Monday's news.

In semiconductor-investing land, twin titans AMD (NYSE:AMD) and Intel (NASDAQ:INTC) get all the press. But has either one beat Wall Street estimates in every quarter since the third quarter of 2001? Hardly. To find a chip company that can make that boast, you need to shift your attention from the big names to little Silicon Labs (NASDAQ:SLAB).

Better focus quickly, though. This Motley Fool Stock Advisor recommendation reports its Q3 2006 earnings Monday morning.

What analysts say:

  • Buy, sell, or waffle? A dozen analysts follow "Silabs," and buy ratings outnumber holds 2-to-1.
  • Revenues. On average, analysts think the company will report another 11% rise in quarterly revenues, this time to $115.5 million.
  • Earnings. Profits, however, are predicted to fall 12% to $0.23 per share.

What management says:
Last month, Silicon Labs updated investors on what to expect in Monday's news: nothing good. Management slashed 8% from its sales expectations, substituting a new range of $113 million to $116 million, and predicted that GAAP profits would come in light as well -- somewhere in the neighborhood of $0.05 to $0.08 per share. Of course, GAAP profits might have been as much as $0.25 per share. A $0.03 charge for writing off in-process research and development on an acquisition, and a $0.14 charge for stock options expensing, explain the lower number under GAAP (generally accepted accounting principles). The firm blamed weak demand for its Aero transceivers and analog modem components, as well as continuing inventory bloat among Chinese customers, for the probable sales shortfall.

What management does:
Silabs has successfully kept its rolling gross margins moving upward over the past year. Operating and net margins, however, are another matter entirely. Thanks to rapidly rising selling, general, and administrative expenses, or SG&A, hefty investments in research and development (R&D) -- and yes, large charges to expense stock options -- over the past 18 months, the company's operating margin was nearly, and its net margin more than, cut in half.

Margins %

4/05

7/05

10/05

12/05

4/06

7/06

Gross

54.6

54.7

54.4

54.4

54.8

55.6

Op.

25.0

23.1

17.3

14.3

11.9

14.2

Net

16.6

15.6

11.0

11.2

9.5

7.9

All data courtesy of Capital IQ, a division of Standard & Poor's. Data reflects trailing-12-month performance for the quarters ended in the named months.

One Fool says:
How fast is "rapid?" How massive is "hefty?" Let's take a look.

Year to date, Silicon Labs' revenues have grown a respectable 12% versus last year's first half. Cost of goods sold, which rose just 7% over the same period, helps to explain the firm's strengthening gross margins.

The damage to the net resides farther down the income statement. There we find that SG&A costs grew at nearly three times the pace of sales gains -- 35% year over year. Meanwhile, R&D spending more than doubled to 32%. That, I fully understand -- high tech is an R&D-driven business, and the more Silabs spends to keep its technology at the head of the pack, the happier investors should be. The rapid rise in SG&A costs is more worrisome, however. Given my druthers, I'd much rather see a much lower SG&A number in Monday's news.

Speaking of wish lists, another number I'll be watching is accounts receivable. So far this year, they've spiked -- up 74%, or six times the rate of sales growth. The fact that average inventories are growing less quickly than sales (at 7%) is nice, of course. But I have to wonder whether Silabs' suggestion in September that its customers have more chips than they can use is related to its trouble in getting customers to pay promptly.

Competitors:

  • Agere (NYSE:AGR)
  • Broadcom (NASDAQ:BRCM)
  • Infineon (NYSE:IFX)
  • Texas Instruments (NYSE:TXN)

How do we love thee, Silicon Labs? Let me count the ways. One, two, three -- Silicon Labs is a three-time recommendation of Motley Fool Stock Advisor .

Intel is a Motley Fool Inside Value pick. What is Wall Street overlooking now?Inside Valuegives subscribers the big names with the best prospects for good returns. A free trial gives you all the picks and how they're doing.

Fool contributor Rich Smith owns shares of Intel. The Fool has a disclosure policy.

None

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Silicon Laboratories Inc. Stock Quote
Silicon Laboratories Inc.
SLAB
$122.94 (-0.07%) $0.08
Intel Corporation Stock Quote
Intel Corporation
INTC
$27.52 (-1.96%) $0.55
Texas Instruments Incorporated Stock Quote
Texas Instruments Incorporated
TXN
$161.29 (-0.82%) $-1.33
Advanced Micro Devices, Inc. Stock Quote
Advanced Micro Devices, Inc.
AMD
$67.96 (-2.22%) $-1.54

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.